Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - ANI PHARMACEUTICALS INC | c98259e10vk.htm |
| EX-4.9 - EXHIBIT 4.9 - ANI PHARMACEUTICALS INC | c98259exv4w9.htm |
| EX-31.1 - EXHIBIT 31.1 - ANI PHARMACEUTICALS INC | c98259exv31w1.htm |
| EX-32.1 - EXHIBIT 32.1 - ANI PHARMACEUTICALS INC | c98259exv32w1.htm |
| EX-31.2 - EXHIBIT 31.2 - ANI PHARMACEUTICALS INC | c98259exv31w2.htm |
| EX-32.2 - EXHIBIT 32.2 - ANI PHARMACEUTICALS INC | c98259exv32w2.htm |
| EX-10.23 - EXHIBIT 10.23 - ANI PHARMACEUTICALS INC | c98259exv10w23.htm |
| EX-10.22 - EXHIBIT 10.22 - ANI PHARMACEUTICALS INC | c98259exv10w22.htm |
| EX-10.39 - EXHIBIT 10.39 - ANI PHARMACEUTICALS INC | c98259exv10w39.htm |
| EX-10.12 - EXHIBIT 10.12 - ANI PHARMACEUTICALS INC | c98259exv10w12.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-151660, 333-151663,
333-109474, 333-100238 and 333-53384 on Form S-8 and in Registration Statement Nos. 333-159606,
333-144665, 333-136852, and 333-64218 on Form S-3 of our report dated March 29, 2010, relating to
the financial statements of BioSante Pharmaceuticals, Inc., appearing in this Annual Report on Form
10-K of BioSante Pharmaceuticals, Inc. for the year ended December 31, 2009.
/s/ Deloitte & Touche LLP
Deloitte & Touche LLP
Chicago, Illinois
March 29, 2010
March 29, 2010